Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Macular symbols : Nvs save search
Diabetic Macular Edema Treatment Global Market Report 2022: Prevalence of Diabetes Worldwide Bolsters Sector
Published: 2023-01-16 (Crawled : 12:00) - prnewswire.com
IEX | $227.04 0.42% 0.0% 240K
|
Producer Manufacturing
| Email alert
Add to watchlist
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
IRIX | $2.95 -2.32% -2.37% 50K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
treatment global report macular diabetes market diabetic
Outlook on the Age-related Macular Degeneration Global Market to 2030 - Players Include Bayer, Pfizer, Bausch Health and Amgen Among Others
Published: 2022-12-14 (Crawled : 13:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.74%
H: 0.45%
C: -1.8%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.0%
H: 1.29%
C: 0.45%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.39%
H: 3.26%
C: 2.34%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.11%
H: 0.51%
C: -0.31%
global macular health market
Macular Degeneration Treatment Market to Surpass US$ 21.1 Bn by 2031: TMR Study
Published: 2022-09-21 (Crawled : 02:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: -1.99%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.09%
H: 0.38%
C: -1.99%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.73%
H: 0.04%
C: -1.85%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.47%
H: 1.24%
C: -2.32%
treatment macular study market
Macular Degeneration Treatment Global Market to Reach $10.65 Billion by 2026 at a CAGR of 7.15%
Published: 2022-09-14 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.98%
H: 7.63%
C: 2.67%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.55%
H: 0.42%
C: -0.72%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.6%
H: 0.41%
C: -0.76%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 0.41%
H: 11.64%
C: 6.22%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: 0.38%
H: 2.53%
C: 1.48%
treatment global macular market
Global Macular Degeneration Treatment Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-06-09 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.49%
H: 0.47%
C: -1.59%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.89%
H: 0.67%
C: -6.05%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: -0.75%
H: 0.53%
C: -3.07%
treatment report macular market
Macular Degeneration Treatment Market size worth $ 11.98 Billion, Globally, by 2028 at 6.01% CAGR: Verified Market Research®
Published: 2022-02-14 (Crawled : 09:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: -0.81%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.48%
H: 1.52%
C: -1.08%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: 0.92%
H: 0.87%
C: -0.91%
research treatment macular
Beovu (brolucizumab injection) now publicly reimbursed in Ontario and New Brunswick for the treatment of neovascular (wet) age-related macular degeneration
Published: 2021-12-17 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
treatment injection macular
Diabetic Macular Edema Market size worth $ 4.87 Billion, Globally, by 2028 at 2.86% CAGR: Verified Market Research®
Published: 2021-10-07 (Crawled : 13:15) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.72%
H: 0.1%
C: 0.1%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.62%
H: 1.0%
C: 0.22%
KOD | $3.36 -3.17% -3.27% 600K
|
Health Technology
|
| O: 0.34%
H: 4.38%
C: 2.23%
research macular diabetic diabetes
Global $79.2 Billion Kinase Inhibitors Markets to 2026: Antineoplastic Agents, Age-related Macular Degeneration (AMD), Immunosuppressant
Published: 2021-07-02 (Crawled : 22:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
macular dmd
Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept
Published: 2021-05-01 (Crawled : 12:20) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
potential injection macular diabetic diabetes
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.